Literature DB >> 2419812

[Chemotherapy as primary therapy in non-radically operated ovarian cancer].

K W Brunner, A Goldhirsch, R Greiner.   

Abstract

Forthwith the results of chemotherapy on advanced ovarian carcinoma are summarized. The following conclusions can be drawn: stages Ia and Ib of low malignancy degrees should receive follow-up treatment. Stages II and I of high malignancy degrees should receive radiotherapy to the whole abdomen. The value of intensive chemotherapy is examined. Stage II with residual tumor should undergo combined cis-platin treatment for 4 to 6 months. Stage III with residual tumor should receive intensive chemotherapy followed by a second-look operation and radiotherapy to the whole abdomen. The prognosis of cases with large residual tumors is very unfavorable so that the value of radical therapy must be further investigated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2419812     DOI: 10.1159/000215687

Source DB:  PubMed          Journal:  Onkologie        ISSN: 0378-584X


  1 in total

1.  Serum CA-125 as a guideline for the timing of a second-look operation and second-line treatment in ovarian cancer.

Authors:  W Jäger; R Adam; L Wildt; N Lang
Journal:  Arch Gynecol Obstet       Date:  1988       Impact factor: 2.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.